Clinical Trials for Kymera Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kymera Therapeutics

Clinical Trials (4)

NCT07217015
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
PHASE2Recruiting
200 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT06945458
Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
PHASE1Active, not recruiting
20 participants
Started: Apr 17, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor12 locations
NCT06058156
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE2Active, not recruiting
200 participants
Started: Nov 9, 2023 · Completed: Aug 18, 2026
1 condition2 sponsors37 locations
NCT06028230
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
PHASE2Active, not recruiting
156 participants
Started: Sep 29, 2023 · Completed: Jul 17, 2026
1 condition2 sponsors52 locations